Leadership duties shift within CDER

01/31/2012 | Pharmalot.com

Bob Temple is giving up his post as acting director of the Office of Drug Evaluation I at the FDA's Center for Drug Evaluation and Research and will be replaced by Ellis Unger, the office's deputy director. The change will allow Temple to devote more time to his duties as deputy director for clinical science, according to CDER Director Janet Woodcock.

View Full Article in:

Pharmalot.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Food & Drug Associate
Confidential
Washington, D.C., DC